Product category:
Genomics
News Release from: Microbix Biosystems
Edited by the Laboratorytalk Editorial
Team on 30 January 2002
TransAtlantic cell evolution
Nautilus Biotech of France and Microbix Biosystems of Canada announce a distribution agreement for academic applications of NautCell, a high-producer cell-line for recombinant Adeno-associated vectors
NautCell has been developed by Nautilus using its proprietary high- throughput Platform Biomics technology for cell-directed evolution, after more than 40,000 individual recombinant Adeno-associated vectors (rAAV) viral infections with rAAV produced by cell clones obtained from the Microbix 293 HEK cell line NautCell displays a stable 1-2 logs higher productivity for rAAV compared to the parental 293 HEK cells
This article was originally published on Laboratorytalk on 20 Mar 2003 at 8.00am (UK)
Related stories
Double anniversary at Focus
Supplier of one quarter of the world's haematology analysers celebrates its twentieth birthday, while its parent company celebrates its fiftieth
Merger of HTP operations
"With a combined instrumentation and biochemistry team we can respond faster and more flexibly to the assaying demands of current and future customers"
NautCell is a powerful and reliable tool to meet the rapidly growing rAAV manufacturing scale and needs for applications in the fields of gene therapy and vaccines.
"Nautilus's Platform Biomics technology is an excellent tool for optimising and screening a variety of cell lines as demonstrated by their creation of NautCell.
We are pleased to have the opportunity to provide another technology to our customers that will help bring new therapies to market," stated William J Gastle, president and CEO of Microbix.
Nautilus Biotech is is involved in areas it describes as directed evolution, functional genomics target characterisation, and cell-line engineering for complex systems.
Microbix Biosystems specialises in developing and manufacturing tissue culture-derived biologicals for biotherapeutic drugs and vaccines.
It makes reagents for building diagnostic products and tools used in biotechnology research.
The company has expertise in advanced culture, purification and process validation technologies.
• Microbix Biosystems: contact details and other news
• Email this article to a colleague
• Register for the free Laboratorytalk email newsletter
• Laboratorytalk Home Page
Search the Pro-Talk network of sites
